Copyright
©The Author(s) 2022.
World J Clin Cases. Aug 26, 2022; 10(24): 8599-8614
Published online Aug 26, 2022. doi: 10.12998/wjcc.v10.i24.8599
Published online Aug 26, 2022. doi: 10.12998/wjcc.v10.i24.8599
Measure | Control group (TAU), n= 51 | Intervention group (UP), n= 51 | ||
Time 1 | Time 1I | Time 1 | Time 1I | |
Anxiety | 11.35 ± 2.05 | 11.75 ± 2.42 | 10.88 ± 1.69 | 8.54 ± 2.83 |
Depression | 11.24 ± 1.75 | 12.08 ± 2.16 | 10.71 ± 1.70 | 8.14 ± 3.03 |
Emotion difficulties | 49.07 ± 7.32 | 50.31 ± 8.40 | 50.18 ± 8.04 | 47.33 ± 9.41 |
Positive affect | 26.88 ± 3.92 | 26.99 ± 4.22 | 26.10 ± 3.66 | 31.97 ± 3.59 |
Negative affect | 26.59 ± 3.66 | 27.89 ± 3.74 | 27.74 ± 3.01 | 23.31 ± 4.92 |
Healthy emotionality | 60.33 ± 9.46 | 59.47 ± 10.41 | 58.90 ± 11.35 | 65.12 ± 10.76 |
- Citation: Yan K, Yusufi MH, Nazari N. Application of unified protocol as a transdiagnostic treatment for emotional disorders during COVID-19: An internet-delivered randomized controlled trial. World J Clin Cases 2022; 10(24): 8599-8614
- URL: https://www.wjgnet.com/2307-8960/full/v10/i24/8599.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i24.8599